-
Number of
employees47,000
Japan
17,500
Outside Japan
29,500 -
Total group
companies200
Japan
49
Outside Japan
151 -
R&D sites
44 sites
Japan
24 sites
Outside Japan
20 sites -
Manufacturing
sites175 sites
Japan
50 sites
Outside Japan
125 sites
(As of December 31, 2021)
Fiscal 2021 consolidated revenue
¥1,498.3 billion
Fiscal 2021 business profit*
¥157.1 billion
Revenue by Business Segment
(Fiscal 2021)
•Pharmaceuticals
¥977.5 billion
•Nutraceuticals
¥376.6 billion
•Consumer Products
¥31.9 billion
•Others
¥112.3 billion
Revenue by Geographical Segment
(Fiscal 2021)
•Japan
¥647.2 billion
•North America
¥509.7 billion
•Europe
¥156.7 billion
•Others
¥184.6 billion
* Business profit = Revenue − Cost of sales − Selling, general and administrative expenses + Share of profit of associates − R&D expenses